These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

270 related articles for article (PubMed ID: 21543505)

  • 21. NSs protein of Rift Valley fever virus blocks interferon production by inhibiting host gene transcription.
    Billecocq A; Spiegel M; Vialat P; Kohl A; Weber F; Bouloy M; Haller O
    J Virol; 2004 Sep; 78(18):9798-806. PubMed ID: 15331713
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Rescue of infectious rift valley fever virus entirely from cDNA, analysis of virus lacking the NSs gene, and expression of a foreign gene.
    Ikegami T; Won S; Peters CJ; Makino S
    J Virol; 2006 Mar; 80(6):2933-40. PubMed ID: 16501102
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Protein Kinase R Degradation Is Essential for Rift Valley Fever Virus Infection and Is Regulated by SKP1-CUL1-F-box (SCF)FBXW11-NSs E3 Ligase.
    Mudhasani R; Tran JP; Retterer C; Kota KP; Whitehouse CA; Bavari S
    PLoS Pathog; 2016 Feb; 12(2):e1005437. PubMed ID: 26837067
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Rift valley fever virus nonstructural protein NSs promotes viral RNA replication and transcription in a minigenome system.
    Ikegami T; Peters CJ; Makino S
    J Virol; 2005 May; 79(9):5606-15. PubMed ID: 15827175
    [TBL] [Abstract][Full Text] [Related]  

  • 25. The NSs Protein Encoded by the Virulent Strain of Rift Valley Fever Virus Targets the Expression of Abl2 and the Actin Cytoskeleton of the Host, Affecting Cell Mobility, Cell Shape, and Cell-Cell Adhesion.
    Bamia A; Marcato V; Boissière M; Mansuroglu Z; Tamietti C; Romani M; Simon D; Tian G; Niedergang F; Panthier JJ; Flamand M; Souès S; Bonnefoy E
    J Virol; 2020 Dec; 95(1):. PubMed ID: 33087469
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Characterizing the effect of Bortezomib on Rift Valley Fever Virus multiplication.
    Keck F; Amaya M; Kehn-Hall K; Roberts B; Bailey C; Narayanan A
    Antiviral Res; 2015 Aug; 120():48-56. PubMed ID: 26001632
    [TBL] [Abstract][Full Text] [Related]  

  • 27. NSs protein of severe fever with thrombocytopenia syndrome virus suppresses interferon production through different mechanism than Rift Valley fever virus.
    Zhang S; Zheng B; Wang T; Li A; Wan J; Qu J; Li CH; Li D; Liang M
    Acta Virol; 2017; 61(3):289-298. PubMed ID: 28854793
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Elongin C Contributes to RNA Polymerase II Degradation by the Interferon Antagonist NSs of La Crosse Orthobunyavirus.
    Schoen A; Lau S; Verbruggen P; Weber F
    J Virol; 2020 Mar; 94(7):. PubMed ID: 31941775
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Mutation of adjacent cysteine residues in the NSs protein of Rift Valley fever virus results in loss of virulence in mice.
    Monteiro GER; Jansen van Vuren P; Wichgers Schreur PJ; Odendaal L; Clift SJ; Kortekaas J; Paweska JT
    Virus Res; 2018 Apr; 249():31-44. PubMed ID: 29530722
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Genetic evidence for an interferon-antagonistic function of rift valley fever virus nonstructural protein NSs.
    Bouloy M; Janzen C; Vialat P; Khun H; Pavlovic J; Huerre M; Haller O
    J Virol; 2001 Feb; 75(3):1371-7. PubMed ID: 11152510
    [TBL] [Abstract][Full Text] [Related]  

  • 31. TFIIH transcription factor, a target for the Rift Valley hemorrhagic fever virus.
    Le May N; Dubaele S; Proietti De Santis L; Billecocq A; Bouloy M; Egly JM
    Cell; 2004 Feb; 116(4):541-50. PubMed ID: 14980221
    [TBL] [Abstract][Full Text] [Related]  

  • 32. The Change P82L in the Rift Valley Fever Virus NSs Protein Confers Attenuation in Mice.
    Borrego B; Moreno S; de la Losa N; Weber F; Brun A
    Viruses; 2021 Mar; 13(4):. PubMed ID: 33805122
    [TBL] [Abstract][Full Text] [Related]  

  • 33. The role of signal transducer and activator of transcription 3 in Rift Valley fever virus infection.
    Pinkham C; An S; Lundberg L; Bansal N; Benedict A; Narayanan A; Kehn-Hall K
    Virology; 2016 Sep; 496():175-185. PubMed ID: 27318793
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Nuclear relocalization of polyadenylate binding protein during rift valley fever virus infection involves expression of the NSs gene.
    Copeland AM; Altamura LA; Van Deusen NM; Schmaljohn CS
    J Virol; 2013 Nov; 87(21):11659-69. PubMed ID: 23966414
    [TBL] [Abstract][Full Text] [Related]  

  • 35. A SAP30 complex inhibits IFN-beta expression in Rift Valley fever virus infected cells.
    Le May N; Mansuroglu Z; Léger P; Josse T; Blot G; Billecocq A; Flick R; Jacob Y; Bonnefoy E; Bouloy M
    PLoS Pathog; 2008 Jan; 4(1):e13. PubMed ID: 18225953
    [TBL] [Abstract][Full Text] [Related]  

  • 36. [Rift Valley fever virus].
    Ikegami T; Makino S
    Uirusu; 2004 Dec; 54(2):229-35. PubMed ID: 15745161
    [TBL] [Abstract][Full Text] [Related]  

  • 37. NSs Filament Formation Is Important but Not Sufficient for RVFV Virulence In Vivo.
    Li S; Zhu X; Guan Z; Huang W; Zhang Y; Kortekaas J; Lozach PY; Peng K
    Viruses; 2019 Sep; 11(9):. PubMed ID: 31500343
    [TBL] [Abstract][Full Text] [Related]  

  • 38. A single-cycle replicable Rift Valley fever phlebovirus vaccine carrying a mutated NSs confers full protection from lethal challenge in mice.
    Terasaki K; Juelich TL; Smith JK; Kalveram B; Perez DD; Freiberg AN; Makino S
    Sci Rep; 2018 Nov; 8(1):17097. PubMed ID: 30459418
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Rift Valley fever virus NSS gene expression correlates with a defect in nuclear mRNA export.
    Copeland AM; Van Deusen NM; Schmaljohn CS
    Virology; 2015 Dec; 486():88-93. PubMed ID: 26410240
    [TBL] [Abstract][Full Text] [Related]  

  • 40. The nonstructural protein NSs induces a variable antibody response in domestic ruminants naturally infected with Rift Valley fever virus.
    Fernandez JC; Billecocq A; Durand JP; Cêtre-Sossah C; Cardinale E; Marianneau P; Pépin M; Tordo N; Bouloy M
    Clin Vaccine Immunol; 2012 Jan; 19(1):5-10. PubMed ID: 22072723
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 14.